Retracing Micro-Epidemics of Chagas Disease Using Epicenter Regression

PLoS Computational Biology

Volumn 7, Issue 9, 2011, Pages

  Levy, Michael Z ^a   Small, Dylan S ^b   Vilhena, Daril A ^c   Bowman, Natalie M ^d   Kawai, Vivian ^e   Cornejo del Carpio, Juan G ^f   Cordova Benzaquen, Eleazar ^g   Gilman, Robert H ^h   Bern, Caryn ⁱ   Plotkin, Joshua B ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^f Dirección Regional del Ministerio de Salud   (Peru)

^g UNIVERSIDAD NACIONAL DE SAN AGUSTÍN DE AREQUIPA   (Peru)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE HYPOTHESIS; CHAGAS DISEASE; CLINICAL DISEASE; DISEASE TRANSMISSION; EPICENTRE; ETIOLOGIC AGENTS; LATE STAGE; LOCAL STRAINS; TRYPANOSOMA CRUZI; URBAN PROBLEMS;

DISEASE CONTROL;

DELTAMETHRIN;

ARTICLE; CHAGAS DISEASE; COMMUNITY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPICENTER REGRESSION; EPIDEMIC; HUMAN; NONHUMAN; PARASITE TRANSMISSION; PERU; STATISTICAL ANALYSIS; TRIATOMA INFESTANS; TRYPANOSOMA CRUZI; VECTOR CONTROL; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; PATHOGENICITY;

CHAGAS DISEASE; CROSS-SECTIONAL STUDIES; EPIDEMICS; HUMANS; PERU; SEROEPIDEMIOLOGIC STUDIES; TRYPANOSOMA CRUZI;

EID: 84857660340     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002146     Document Type: Article

References (46)

1. WHO Expert Committee.(2002) Control of Chagas Disease. 109; WHO Technical Report Series Number 905: 1.
2. Levy MZ, Kawai V, Bowman NM, Waller LA, Cabrera L, et al.(2007) Targeted screening strategies to detect trypanosoma cruzi infection in children. PLoS Negl Trop Dis 1: e103.
3. Bowman NM, Kawai V, Levy MZ, Cornejo del Carpio JG, Cabrera L, et al.(2008) Chagas disease transmission in periurban communities of Arequipa, Peru. Clin Infect Dis 46: 1822-8.
4. Fraser B, (2008) Controlling Chagas' disease in urban Peru. Lancet 372: 16-7.
5. Magalhaes JB, Pontes AL, Andrade SG, (1985) Behavior of the Y and Peruvian strains of trypanosoma cruzi in mice, after passage through various media. Mem Inst Oswaldo Cruz 80: 41-50.
6. Lima ES, Andrade ZA, Andrade SG, (2001) TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with trypanosoma cruzi. Int J Exp Pathol 82: 327-36.
7. Schofield CJ, Jannin J, Salvatella R, (2006) The future of Chagas disease control. Trends Parasitol 22: 583-8.
8. Pinto Dias JC, (1995) Natural history of Chagas disease. Arq Bras Cardiol 65: 359-66.
9. Bern C, Montgomery SP, Herwaldt BL, R A Jr, Marin-Neto JA, et al.(2007) Evaluation and treatment of Chagas disease in the United States: A systematic review. JAMA 298: 2171-81.
10. Maguire JH, Hoff R, Sherlock I, Guimaraes AC, Sleigh AC, et al.(1987) Cardiac morbidity and mortality due to Chagas' disease: Prospective electrocardiographic study of a Brazilian community. Circulation 75: 1140-5.
11. Reyes PA, Vallejo M, (2005) Trypanocidal drugs for late stage, symptomatic Chagas disease (trypanosoma cruzi infection). Cochrane Database Syst Rev 2005 Oct 19: CD004102.
12. Barbu C, Dumonteil E, Gourbiere S, (2009) Optimization of control strategies for non-domiciliated triatoma dimidiata, Chagas disease vector in the yucatan peninsula, mexico. PLoS Negl Trop Dis 3: e416.
13. Zu Dohna H, Cecere MC, Gurtler RE, Kitron U, Cohen JE, (2009) Spatial re-establishment dynamics of local populations of vectors of Chagas disease. PLoS Negl Trop Dis 3: e490.
14. Levy MZ, Bowman N, Kawai V, Waller LA, Cornejo del Carpio J, et al.(2006) Peri-urban infestation by triatoma infestans carrying trypanosoma cruzi in Arequipa, Peru. Emerg Infect Dis 12: 1345-1352.
15. Levy MZ, Kawai V, Bowman NM, Waller LA, Cabrera L, et al.(2007) Targeted screening strategies to detect trypanosoma cruzi infection in children. PLoS Negl Trop Dis 1: e103.
16. Mott KE, LJ S Jr, hoff R, Morrow RH, Muniz TM, et al.(1976) The epidemiology and household distribution of seroreactivity to trypanosoma cruzi in a rural community in northeast Brazil. Am J Trop Med Hyg 25: 552-62.
17. Paz-Bailey G, Monroy C, Rodas A, Rosales R, Tabaru R, et al.(2002) Incidence of trypanosoma cruzi infection in two Guatemalan communities. Trans R Soc Trop Med Hyg 96: 48-52.
18. Gurtler RE, Cecere MC, Lauricella MA, Petersen RM, Chuit R, et al.(2005) Incidence of trypanosoma cruzi infection among children following domestic reinfestation after insecticide spraying in rural northwestern Argentina. Am J Trop Med Hyg 73: 95-103.
19. Black CL, Ocana S, Riner D, Costales JA, Lascanro MS, et al.(2007) Household risk factors for trypanosoma cruzi seropositivity in two geographic regions of Ecuador. J Parasitol 93: 12-6.
20. Levy MZ, Bowman NM, Kawai V, Plotkin JB, Waller LA, et al.(2009) Spatial patterns in discordant diagnostic test results for Chagas disease: Links to transmission hotspots. Clin Infect Dis 48: 1104-6.
21. Beale CM, Lennon JJ, Yearsley JM, Brewer MJ, Elston DA, (2010) Regression analysis of spatial data. Ecol Lett 13: 246-264.
22. Boyd HA, Flanders WD, Addiss DG, Waller LA, (2005) Residual spatial correlation between geographically referenced observations: A Bayesian hierarchical modeling approach. Epidemiology 16: 532-41.
23. Okubo A, Levin SA, Okubo A, (2001) Diffusion and ecological problems: Modern perspectives. New York Springer.
24. Smith DL, Lucey B, Waller LA, Childs JE, Real LA, (2002) Predicting the spatial dynamics of rabies epidemics on heterogeneous landscapes. Proc Natl Acad Sci U S A 99: 3668-72.
25. Keeling MJ, Woolhouse ME, Shaw DJ, Matthews L, Chase-Topping M, et al.(2001) Dynamics of the 2001 UK foot and mouth epidemic: Stochastic dispersal in a heterogeneous landscape. Science 26: 813-817.
26. Jewell CP, Keeling MJ, Roberts GO, (2008) Predicting undetected infections during the 2007 foot-and-mouth disease outbreak. J R Soc Interface 6: 1145-51.
27. Legrand J, Egan JR, Hall IM, Cauchemez S, Leach S, et al.(2009) Estimating the location and spatial extent of a covert anthrax release. PLoS Comput Biol 5: e1000356.
28. Gelman A, (2004) Bayesian data analysis. Boca Raton, Fla Chapman & Hall/CRC.
29. Halloran ME, (1998) Concepts of infectious disease epidemiology. In: Rothman KJ, Greenland S, editors. Modern Epidemiology Philadelphia, PA Lippincott-Raven pp. 529-554.
30. Muench H, (1959) Catalytic models in epidemiology. Cambridge, Harvard University Press 110.
31. Gurtler RE, Cecere MC, Lauricella MA, Cardinal MV, Kitron U, et al.(2007) Domestic dogs and cats as sources of trypanosoma cruzi infection in rural northwestern Argentina. Parasitology 134: 69-82.
32. McCullagh P, Nelder JA, (1998) Generalized linear models. Boca Raton Chapman & Hall/CRC 511.
33. Gilks WR, Richardson S, Spiegelhalter DJ, (1998) Markov chain Monte Carlo in practice. Boca Raton, Fla Chapman & Hall.
34. Kass RE, Raftery AE, (1995) Bayes factors. Journal of the American Statistical Association 90: 773-795.
35. Geweke J, (1992) Evaluating the accuracy of sampling-based approaches to calculating posterior moments. In: Bernado JM, Berger JO, Dawid AP, Smith AFM, editors. Bayesian Statistics 4 Oxford, UK Clarendon Press.
36. Gelman A, Rubin Donald B, (1992) Inference from iterative simulation using multiple sequences. Statistical Science 7: 457-472.
37. Breniere SF, Llanos B, Tibayrenc M, Desjeux P, (1985) Isoenzymic studies and epidemiological data of trypanosoma cruzi from Arequipa (Peru), pacific side. Ann Soc Belg Med Trop 65 (Suppl 1): 63-6.
38. Breniere SF, Lopez J, Vargas F, Barnabe C, (1997) Genetic variability and microdistribution of triatoma infestans genotypes and trypanosoma cruzi clones in Arequipa region (Peru). Mem Inst Oswaldo Cruz 92: 401-8.
39. Brisse S, Verhoef J, Tibayrenc M, (2001) Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six trypanosoma cruzi lineages. Int J Parasitol 31: 1218-1226.
40. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, et al.(2006) Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: A nonrandomized trial. Ann Intern Med 144: 724-34.
41. Sosa-Estani S, Segura EL, (2006) Etiological treatment in patients infected by trypanosoma cruzi: Experiences in Argentina. Curr Opin Infect Dis 19: 583-7.
42. Cohen JE, Gurtler RE, (2001) Modeling household transmission of American trypanosomiasis. Science 293: 694-8.
43. Bayer AM, Hunter GC, Gilman RH, Cornejo Del Carpio JG, Naquira C, et al.(2009) Chagas disease, migration and community settlement patterns in Arequipa, Peru. PLoS Negl Trop Dis 3: e567.
44. Melbourne BA, Hastings A, (2009) Highly variable spread rates in replicated biological invasions: Fundamental limits to predictability. Science 325: 1536-9.
45. Green PJ, (1995) Reversible jump Markov Chain Monte Carlo computation and Bayesian model determination. Biometrika 82: 711-732.
46. Delgado S, Castillo Neyra R, Quispe Machaca VR, Ancca Juárez J, Chou Chu L, et al.(2011) A history of Chagas disease transmission, control, and re-emergence in peri-rural La Joya, Peru. PLoS Negl Trop Dis 5: e970.